Potent activity of peripheral blood lymphocytes in inducing hepatocyte stimulating factor and urokinase in monocytes.
As fibrinogen is an independent risk factor for arterial thrombosis we were interested in analysing the mechanism controlling fibrinogen biosynthesis. In this work, we showed that incubation of monocytes with lymphocytes increased hepatocyte stimulating factor (HSF) production. Different mechanisms are involved and our results demonstrated that this effect is in part mediated by an increase in interleukin 6 (IL-6) production. However, IL-6 cannot account for the whole effect and other cytokines could be implicated. In addition, we observed a stimulation of urokinase-type plasminogen activator (u-PA) associated with monocytes when these cells were incubated with lymphocytes for 18 h at 37 degrees C. By producing fragment D (fibrinogen degradation product) and D-dimer (fibrin degradation product) this fibrinolytic activity might also contribute to fibrinogen biosynthesis by hepatocytes.
Vasse
M
M
DIFEMA, Faculté de Médecine et de Pharmacie de Rouen, Saint-Etienne du Rouvray, France.
Mirshahi
S S
SS
Soria
J
J
Mirshahi
M
M
Borg
J Y
JY
Monconduit
M
M
Soria
C
C
D002478:Cells, Cultured / Q000378:metabolism; D005338:Fibrin Fibrinogen Degradation Products; D005340:Fibrinogen / Q000096:biosynthesis; D006801:Humans; D015850:Interleukin-6 / Q000378:metabolism* / Q000494:pharmacology*; D008214:Lymphocytes / Q000502:physiology*; D009000:Monocytes / Q000187:drug effects / Q000378:metabolism*; D010960:Plasminogen Activators / Q000378:metabolism; D014568:Urokinase-Type Plasminogen Activator / Q000378:metabolism*
D005338:Fibrin Fibrinogen Degradation Products; D015850:Interleukin-6; D005340:Fibrinogen; D010960:Plasminogen Activators; D014568:Urokinase-Type Plasminogen Activator